| Literature DB >> 24363509 |
Ko Eun Lee1, Pham Ngoc Khoi1, Yong Xia1, Jung Sun Park1, Young Eun Joo1, Kyung Keun Kim1, Seok Yong Choi1, Young Do Jung1.
Abstract
Helicobacter pylori (H. pylori) is a major etiological factor in the development of gastric cancer. Large-scale epidemiological studies have confirmed the strong association between H. pylori infection and both cancer development and progression. Interleukin-8 (IL-8) is overexpressed in gastric mucosa exposed to H. pylori. The expression of IL-8 directly correlates with a poor prognosis in gastric cancer. IL-8 is multifunctional. In addition to its potent chemotactic activity, it can induce proliferation and migration of cancer cells. In this review, we focus on recent insights into the mechanisms of IL-8 signaling associated with gastric cancer. The relationship between IL-8 and H. pylori is discussed. We also summarize the current therapeutics against IL-8 in gastric cancer.Entities:
Keywords: Gastric cancer; Helicobacter pylori; Interleukin-8; Signals; Therapeutics
Mesh:
Substances:
Year: 2013 PMID: 24363509 PMCID: PMC3857441 DOI: 10.3748/wjg.v19.i45.8192
Source DB: PubMed Journal: World J Gastroenterol ISSN: 1007-9327 Impact factor: 5.742